Learning objectives
The course aims at developing knowledge and understanding of the epidemiological methods and the role of epidemiology in planning and evaluation of the phenomena of health and health needs.
Understanding of the rationale for centralization of oncohaematological treatments. Knowledge of the tools and theoretical concepts for the study of evaluation and choice strategies of drugs, pharmacovigilance and instruments of government spending. The study of the risk deriving from the use of the drug in view of the prevention and reduction of error in therapy.
Knowledge of structural characteristics, instrumental, procedural guarantee of quality, efficacy and safety of the path.
Knowledge on the main issues related to risk management and improvement actions to be taken to reduce errors in the course of drug therapy.
Prerequisites
Fundamentals of Pharmacology.
Course unit content
Knowledge of the epidemiological measures and the main epidemiological studies, and the role of epidemiology in planning and evaluation of the phenomena of health and health needs.
Knowledge of healthcare associated infections, with a specific focus on infection in Intensive Care Units and surgical site infections.
Understanding of the rationale for centralization of oncohaematological treatments. Knowledge of the tools and theoretical concepts for the study of evaluation and choice strategies of drugs, pharmacovigilance and instruments of government spending. The study of the risk deriving from the use of the drug in view of the prevention and reduction of error in therapy.
Knowledge of structural characteristics, instrumental, procedural guarantee of quality, efficacy and safety of the path.
Knowledge on the main issues related to risk management and improvement actions to be taken to reduce errors in the course of drug therapy.
Full programme
Please refer to the individual programmes of the disciplines.
Bibliography
For reference texts ref please refer to the bibliography of the individual disciplinary modules.
Teaching methods
The course will be held through lectures to Students either in the classroom (“in presenza”) or in synchronous-streaming (“in telepresenza”) on the Teams platform. Therefore, the opportunity of Student/Teacher interaction will be preserved both face to face and remotely, by the simultaneous use of the Teams platform.
Lectures will be supported by slide presentations, which will be available to students on the Elly platform (https://elly.medicina.unipr.it).
Assessment methods and criteria
Written examination, multiple choice test.
In case of the persistence of the health emergency, the exams will be conducted remotely, as follows:
structured written test conducted remotely (by Teams and Elly). The test consists of 31 multiple choice questions on the course contents (reference texts + documents uploaded to Elly during the course). There is no penalty for incorrect answers.
The final mark, reported directly on Esse3, will correspond to the arithmetic average of the assessments obtained in the written test.
Students with SLD / BSE must first contact Le Eli-che: support for students with disabilities, D.S.A., B.E.S. (https://sea.unipr.it/it/servizi/le-eli-che-supporto-studenti-con-disabilita-dsa-bes
Other information
- - -
2030 agenda goals for sustainable development
- - -
